Navigation Links
Trial Shows Stem Cells Provide Long-Term Relief from Dangerous Crohn’s Side Effect
Date:3/31/2015

Durham, NC (PRWEB) March 31, 2015

Stem cells may provide Crohn’s disease sufferers relief from a common, potentially dangerous side effect – fistulas – according to the results of a phase 2 clinical trial published in the latest issue of STEM CELLS Translational Medicine (SCTM). After receiving an injection of their own adipose-derived stem cells (ASC), which are collected from fat tissue, the fistulas in 75 percent of the trial participants were completely healed within eight weeks of their last treatment and remained so two years later.

Crohn's disease is a painful, chronic autoimmune disorder in which the body's immune system attacks the gastrointestinal tract. Inflammation in Crohn’s patients can sometimes extend completely through the intestinal wall and create a fistula — an abnormal connection between the intestine and another organ or skin. Left untreated, a fistula might become infected and form an abscess, which in some cases can be life threatening.

Chang Sik Yu, M.D., Ph.D., of Asan Medical Center in Seoul, Korea, a senior author of the SCTM paper, describes the results of a clinical trial conducted in collaboration with four other hospitals in South Korea, stated, “Crohn’s fistula is one of the most distressing diseases as it decreases patient’s quality of life and frequently recurs. It has been reported to occur in up to 38 percent of Crohn’s patients and over the course of the disease, 10 to 18 percent of them must undergo a proctectomy, which is a surgical procedure to remove the rectum.”

Overall, the treatments currently available for Crohn’s fistula remain unsatisfactory because they fail to achieve complete closure, lower recurrence and limit adverse effects, Dr. Yu said. Given the challenges and unmet medical needs in Crohn’s fistula, attention has turned to stem cell therapy as a possible treatment.

Several studies, including those undertaken by Dr. Yu’s team, suggest that mesenchymal stem cells (MSCs) do indeed improve Crohn’s disease and Crohn’s fistula. Their phase II trial involved 43 patients for a term of one year, over the period from January 2010 to August 2012. The results showed that 82 percent experienced complete closure of fistula eight weeks after the final ASC injection.

“It strongly demonstrated MSCs derived from ASCs are a safe and useful therapeutic tool for the treatment of Crohn’s fistula,” Dr. Yu said.

The latest study was intended to evaluate the long-term outcome by following 41 of the original 43 patients for yet another year. Dr. Yu reported, “Our long-term follow-up found that one or two doses of autologous ASC therapy achieved complete closure of the fistulas in 75 percent of the patients at 24 months, and sustainable safety and efficacy of initial response in 83 percent. No adverse events related to ASC administration were observed. Furthermore, complete closure after initial treatment was well sustained.”

“These results strongly suggest that autologous ASCs may be a novel treatment option for Crohn’s fistulae,” he said.

“Stem cells derived from fat tissue are known to regulate the immune response, which may explain these successful long-term results treating Crohn’s fistulae with a high risk of recurrence,” said Anthony Atala, M.D., Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.

The full article, “Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula,” can be accessed at http://www.stemcellstm.com.

Read the full story at http://www.prweb.com/releases/2015/03/prweb12615608.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH launches trial of investigational genital herpes vaccine
2. Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow
3. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Scheduling of Final Trial in First Round of Federal C.R. Bard Bellwether Vaginal Mesh Lawsuits
4. Clinical trial finds concurrent therapy not necessary to achieve high pathological in breast cancer
5. Adventure To Fitness Offers Trial Weekend For Thanksgiving
6. Optimal Spaces: November 2013 New York City Office, Retail and Industrial Market Report
7. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
8. Weight reduction decreases atrial fibrillation and symptom severity
9. LFoundry Rousset LF 110 Flash Technology Enters Industrial Phase
10. Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Parties’ Submission of Bellwether Trial Proposals in Federal Biomet Hip Replacement Litigation
11. Paid Asthma Clinical Trial Now Enrolling at Achieve Clinical Research Near Birmingham, Alabama; Accepting M/F Patients with Asthma Age 12 - 75
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2018)... ... , ... Lucyd Pte Ltd, the developer of an eShop ... online store. The Lucyd eShop will feature the latest technologies and trends in ... The eShop will have a number of unique benefits over other eyewear shops, ...
(Date:8/2/2018)... ... 02, 2018 , ... Allegheny Health Network (AHN) ... inside and outside the network to vital patient imaging exams, saving valuable time ... other leading hospital systems nationwide in using lifeIMAGE, which expands access to patients’ ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... recruit caregivers to participate in brain cancer caregiver and patient clinical trials at ... Health Services of Southern California. , At the Pacific Neuroscience Institute ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... will explore a range of topics in acute pain management. In The Role ... discuss Michigan OPEN—the Opioid Prescribing Engagement Network—an innovative approach to the opioid epidemic ...
(Date:8/2/2018)... ... August 01, 2018 , ... Primary care ... domestic violence and makes actionable recommendations for victims and their doctors. , A ... of Greater Rochester (RESOLVE) developed the software program. , “Family care practitioners ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... August 02, 2018 , ... ... services, announced today that the practice is expanding into Florida with the opening ... Care Florida (WCF), a premier provider of women’s health care throughout Central Florida. ...
(Date:8/2/2018)... ... August 02, 2018 , ... On July 28, representatives from EarQ , ... in need. This took place at the Bears Care Back to School Health Fair, ... Kankakee and Iroquois counties as they face a new school year. , This was ...
(Date:8/1/2018)... (PRWEB) , ... August 01, 2018 , ... ... announced that it has finalized an agreement to officially acquire the 425-bed Munroe ... TimberRidge free-standing emergency department. It has also finalized the purchase of certain assets. ...
Breaking Medicine Technology: